Sectors

Biohaven Therapeutics co-led Artizan Biosciences' latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.

An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.

The low-code app app development software provider's eight-figure round included BAI and SIG Asia.

Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.

Seiko Epson’s EP-GB fund and Dai-ichi Life helped provide $17.1m for Gitai as it prepares a demonstration of its space robotics technology.

Q&A with Wanja Humanes, investment manager, Swisscom Ventures

Citi's Impact Fund and Mastercard were among the investors as the mobile banking software provider secured $12m in series A funding.

The instalment finance provider, which counts several corporates as investors, almost tripled its valuation to $31bn in the round.

SoftBank is the largest investor in the online real estate portal, which was valued at $6.4bn in its series G round early last year.